TP53 and cancer: Indeed, our results also indicate significant toxicity of santin and cirsimaritin in both cancer cells expressing wild‐type TP53 (AGS, HepG2) and colon adenocarcinoma cells harbouring a TP53 mutation (DLD‐1).51